1. 1104 Effects of Belimumab (BEL) on Renal Outcomes in Patients (pts) With Relapsed and Newly Diagnosed Active Lupus Nephritis (LN). (14th December 2022) Authors: Anders, Hans-Joachim; Rovin, Brad H; Zhao, Ming-Hui; Malvar, Ana; Hiromura, Keiju; Leone, Angela Jones-; Gonzalez-Rivera, Tania; Gilbride, Jennifer; Madan, Anuradha; Green, Yulia; Roth, David A Journal: Lupus science & medicine Issue: Volume 9(2022)Supplement 3 Page Start: A70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 200 Efficacy and safety of belimumab in patients of black race with systemic lupus erythematosus: results from the EMBRACE study. (April 2019) Authors: D'Cruz, David; Maksimowicz-McKinnon, Kathleen; Oates, Jim; Santiago, Mittermayer Barreto; Bass, Damon; Burriss, Susan; Gilbride, Jennifer; Groark, James; Miller, Michelle; Ji, Beulah Journal: Lupus science & medicine Issue: Volume 6(2019)supplement 1 Page Start: A149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Belimumab use during pregnancy: Interim results of the belimumab pregnancy registry. Issue 2 (30th September 2022) Authors: Juliao, Patricia; Wurst, Keele; Pimenta, Jeanne M.; Gemzoe, Kim; Landy, Helain; Moody, M. Anthony; Tilson, Hugh; Covington, Deborah; Moore, Tammy; Marino, Rebecca; Gilbride, Jennifer; Liu, Andrew; Meizlik, Paige; Petri, Michelle Journal: Birth defects research Issue: Volume 115:Issue 2(2023) Page Start: 188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗